NASDAQ:MDGL - Madrigal Pharmaceuticals, Inc.
$105.56
 $-0.69
-0.65%
4:00PM EDT
2019-04-18
Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The Company's lead product, MGL-3196, is a Phase II-ready once-daily, oral, liver-directed selective thyroid hormone receptor-b (THR-b) agonist for the treatment of NASH, and heterozygous and homozygous familial hypercholesterolemia (FH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and FH. MGL-3196 has completed Phase I single and multiple dose trials in healthy volunteers. MGL-3196 is being developed for dyslipidemia/hypercholesterolemia to lower low-density lipoproteins cholesterol, triglyceride levels and lipoprotein(a). MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MDGL     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 99   203. 85   241. 91  
42 stocks rank:  3. 31 K 1. 44 K 1. 05 K
# analyst opinions:  11. 00   14. 51   13. 97  
mean recommendation:  2. 10   2. 09   2. 01  

quick ratio:  57. 28   5. 27   1. 81  
current ratio:  57. 46   5. 62   2. 25  

target price low:  128. 00   84. 80   115. 21  
target price avg:  217. 36   111. 51   137. 51  
target price high:  124. 78   135. 81   157. 84  
1-yr high:  313. 90   114. 23   138. 78  
last close:  105. 56   87. 66   116. 69  
50-day avg:  130. 24   95. 54   123. 44  
200-day avg:  173. 10   94. 25   121. 11  
1-yr low:  94. 77   72. 78   98. 34  
volume:  332. 25 K 4. 11 M 8. 07 M
50-day avg volume:  248. 90 K 2. 76 M 5. 02 M
200-day avg volume:  243. 91 K 2. 92 M 4. 59 M

1-day return:  -0. 65 % -0. 41 % 0. 07 %
this week return:  -16. 77 % -5. 74 % -4. 11 %
12-wk return:  -4. 96 % 1. 61 % -0. 05 %
52-wk return:  -9. 50 % 3. 12 % 8. 78 %

enterprise value (EV):  1. 14 B 48. 94 B 114. 64 B
market cap:  1. 63 B 43. 07 B 104. 73 B
EBITDA:  -40. 59 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -28. 18   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -32. 81 M 2. 20 B 4. 20 B

shares outstanding:  15. 42 M 571. 70 M 1. 24 B
shares:  6. 42 M 571. 81 M 1. 23 B
shares short:  2. 03 M 10. 17 M 13. 00 M
shares short prior month:  1. 87 M 9. 54 M 17. 33 M
short ratio:  8. 50   5. 41   3. 28  
short % of float:  163. 69 % 5. 45 % 2. 38 %
total cash/share:  31. 38   11. 14   9. 33  
total cash:  483. 72 M 6. 71 B 7. 15 B
free cash flow:  -14. 47 M 3. 58 B 2. 96 B
operating cash flow:  -25. 51 M 4. 15 B 4. 30 B

book value:  30. 95   12. 78   26. 92  
price/book:  3. 41   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  144. 96 % --- ---
1-yr mean volatility:  0. 26 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 22   2. 40   4. 10  
forward EPS:  -6. 92   3. 97   7. 13  
P/E:  -47. 61   13. 63   22. 72  
forward P/E:  -15. 25   -15. 95   13. 99  
PE/G:  54. 89   -1. 65   -1. 32  
growth:  -0. 87 % 127. 12 % 29. 61 %
earnings high:  -0. 82   1. 00   1. 66  
earnings avg:  -0. 97   0. 77   1. 53  
earnings low:  -1. 34   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -7. 50 % -2. 75 % 4. 55 %
return on equity:  -9. 95 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  1. 47   1. 25   0. 93  
sharpe (1yr):  0. 41   0. 37   0. 70  

held % insiders:  11. 33 % 6. 39 % 3. 38 %
held % institutions:  97. 08 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : MDGL
.    + 8.057 =         8.057 :: INITIAL WEIGHT
.   + 39.023 =         47.08 :: inverse volume-to-price addition
.     + 34.8 =        81.881 :: spline projection addition
.    x 1.548 =       126.756 :: 13 weeks' performance factor
.     x 0.93 =       117.908 :: one-year gains+dividend factor
.    x 1.431 =       168.776 :: industry recommendation factor
.     x 2.07 =       349.353 :: symbol recommendation factor
.    x 0.999 =       349.091 :: return on assets factor
.    x 0.999 =       348.743 :: return on equity factor
.    x 5.963 =      2079.689 :: current ratio factor
.    x 1.009 =      2098.083 :: quick ratio factor
.    x 1.057 =      2218.068 :: short ratio factor
.    x 2.034 =      4511.775 :: price-to-book factor
.    x 1.021 =      4605.548 :: P/E weight
.    x 0.367 =      1692.022 :: PE/G factor
.    x 1.339 =      2265.582 :: beta factor
.    x 0.414 =       937.608 :: sharpe factor
.    x 1.477 =      1384.551 :: target low factor
.    x 1.343 =      1859.512 :: target mean factor
.    x 1.043 =      1938.853 :: target high factor
.     x 1.31 =      2539.681 :: industry 2-weeks return factor
.    x 0.903 =      2292.567 :: "drift" penalty 2 days ago
.    x 0.879 =       2014.84 :: "drift" penalty 4 days ago
.    x 0.783 =      1578.107 :: overall "drift" factor
.    x 0.999 =      1576.693 :: largest single-day jump factor
.     x 1.01 =      1592.418 :: mean volatility factor
.    x 1.097 =      1746.656 :: 42-day mean volatility factor
.      x 1.0 =      1746.372 :: factor hist industry gain for week 16
.   cubeRoot =        12.042 :: reduced to standardize
.   - 23.239 =         0.988 :: add/subtract for performance
.                      0.988 :: FINAL WEIGHT for NASDAQ:MDGL


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org